3CPM specializes in advanced technologies for diagnosing gastrointestinal diseases, particularly through the use of Electrogastrography (EGG). Their innovative approach combines miniaturized hardware with AI-driven software to provide accurate and timely diagnostics for various gastrointestinal motility disorders, such as gastroparesis and functional dyspepsia. The company’s proprietary technology allows for completely automated signal acquisition, enabling healthcare professionals to personalize diagnosis and therapy based on the subtyping of myoelectrical activity. This non-invasive, 45-minute test is designed to optimize treatment outcomes and define pathways for managing previously uncurable conditions.

In addition to their core EGG technology, 3CPM offers a suite of companion programs tailored for research and hospital environments. These programs enhance the efficiency, portability, and storage of EGG data, allowing for seamless data sharing and collaboration across multiple sites. The 3CPM EGG SAS Export Program facilitates the export of patient files, while the Central Data Depot Reader (CDDR) ensures the integrity and security of data during multicenter research projects. Furthermore, 3CPM provides additional security-based software programming services to address the specific needs of institutional environments, reinforcing their commitment to data protection and integrity in medical diagnostics.

United States

3CPM Corporation is a Medical Technology company that offers a non-invasive 45-minute test using AI-derived patented technology to accurately characterize gastrointestinal motility disorders such as gastroparesis and functional dyspepsia.

3CPM

Company Details